Good clinical practice recommendations for proton pump inhibitor prescription and deprescription. A review by experts from the AMG L.R. Valdovinos-García; A.S. Villar-Chávez; F.M Huerta-Iga; M. Amieva-Balmori; J.S. Arenas-Martínez; R. Bernal-Reyes; E. Coss-Adame; O. Gómez-Escudero; P.C. Gómez-Castaños; M. González-Martínez; E.C Morel-Cerda; J.M. Remes-Troche; M.C. Rodríguez-Leal; D. Ruiz-Romero; M.A. Valdovinos-Diaz; G. Vázquez-Elizondo; J.A. Velarde-Ruiz Velasco; M.R. Zavala-Solares;

Transitioning from NAFLD to MAFLD to MASLD in the Mexican population B.A. Priego-Parra; R. Bernal-Reyes; M.E. Icaza-Chávez; S.E. Martínez-Vázquez; J.M. Remes-Troche;

Comparative evaluation of APRI, FIB-4, HFS, and NFS: Scoring tools for liver fibrosis in a Mexican population with MASLD B.A. Priego-Parra; A. Triana-Romero; R. Bernal-Reyes; M.E. Icaza-Chávez; S.E. Martínez-Vázquez; M. Amieva-Balmori; A.D. Cano-Contreras; H. Vivanco-Cid; J.M. Remes-Troche;